Literature DB >> 3263997

Measurement of anti-Haemophilus influenzae type b capsular polysaccharide antibodies by ELISA.

A Barra1, D Schulz, P Aucouturier, J L Preud'homme.   

Abstract

Measurement of antibodies to the capsular polysaccharide polyribosylribitolphosphate (PRP) of Haemophilus influenzae type b by ELISA is made difficult by the poor binding of this antigen to the solid phase. Six coating conditions were compared using immune and non-immune human sera. Direct coating with PRP was inefficient. Precoating with protamine or poly-L-lysine (PLL) yielded irreproducible results and high background levels. Assays with PRP conjugated with PLL as coat were not sensitive enough. In addition, anti-PRP antibodies, especially those belonging to the IgM class, crossreacted with PLL. Coating with avidin or streptavidin followed by incubation with biotin-coupled PRP was not satisfactory either, due to binding of certain sera in the absence of PRP. Coating with PRP coupled to tyramine resulted in low backgrounds and acceptable specific binding levels. However, the finding that the binding of a few sera was only partially inhibited by soluble PRP led us to include an inhibition step in every experiment. Only optical densities inhibited by the antigen were taken into account. In view of the lack of parallelism of dilution curves from different sera, no attempt was made to express the results in weight units. They were expressed in arbitrary units calculated by comparison with internal standards. Under such conditions, the assay permitted a reproducible (interassay coefficients of variation around 10%) determination of PRP-Ab belonging to the various immunoglobulin classes and IgG subclasses and showed a good correlation with results obtained using the Farr assay.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263997     DOI: 10.1016/0022-1759(88)90317-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Antibody response to Prevotella spp. in patients with ventilator-associated pneumonia.

Authors:  G Grollier; P Doré; R Robert; P Ingrand; C Gréjon; J L Fauchere
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

2.  Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay.

Authors:  D V Madore; P Anderson; B D Baxter; G M Carlone; K M Edwards; R G Hamilton; P Holder; H Käyhty; D C Phipps; C C Peeters; R Schneerson; G R Siber; J I Ward; C E Frasch
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria.

Authors:  M J Rodrigo; M Miravitlles; M J Cruz; J de Gracia; M Vendrell; C Pascual; F Morell
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

4.  Immunogenicity and reactogenicity of HbOC vaccine administered simultaneously with acellular pertussis vaccine (DTaP) into either arms or thighs of infants.

Authors:  H J Schmitt; C H Wirsing von König; F Zepp; J Huff; K Jahn; P Schmidtke; C Meyer; P Habermehl; R Uhlenbusch; P Angersbach
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

5.  Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.

Authors:  G Arakere; C E Frasch
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.

Authors:  L L Gheesling; G M Carlone; L B Pais; P F Holder; S E Maslanka; B D Plikaytis; M Achtman; P Densen; C E Frasch; H Käyhty
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

7.  Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharide.

Authors:  Herman F Staats; Shaun M Kirwan; Carol C Whisnant; James L Stephenson; Diane K Wagener; Partha P Majumder
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

8.  Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies.

Authors:  Peter Rigsby; Emma Beamish; Jason Hockley; Eleanor Atkinson; Krisztina Hitri; Elizabeth Jones; Jae Seung Yang; Firdausi Qadri; Novilia S Bachtiar; Sean C Elias; Akshay Goel; Ravipratapnarayan Mishra; Raju Dugyala; Marcela F Pasetti; James E Meiring; Maurice Mbewe; Melita A Gordon; Andrew J Pollard; Alastair Logan; Sjoerd Rijpkema
Journal:  Biologicals       Date:  2020-06-20       Impact factor: 1.856

9.  Development and Optimization of a Homemade ELISA Kit for Detection of Antibodies Against Haemophilus influenzae Type b.

Authors:  Seyed Fazlolah Mousavi; Sara Fatemi; Seyed Davar Siadat; Seyed Mohsen Zahraei; Elnaz Nikanpour; Mohamad Ali Malekan; Ali Reza Khabiri; Ali Reza Janani
Journal:  Jundishapur J Microbiol       Date:  2016-02-17       Impact factor: 0.747

10.  Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.

Authors:  Sjoerd Rijpkema; Jason Hockley; Alastair Logan; Peter Rigsby; Eleanor Atkinson; Celina Jin; David Goldblatt; Haoyu Liang; Novilia S Bachtiar; Jae Seung Yang; Akshay Goel; Venkatesan Ramasamy; Marcela F Pasetti; Andrew J Pollard
Journal:  Biologicals       Date:  2018-09-07       Impact factor: 1.856

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.